Christopher J. Testa
Christopher J. Testa has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Bayan Takizawa
CONTINUUS Pharmaceuticals, 25R Olympia Avenue, Woburn, Massachusetts 01801, United States
6 shared publications- Chuntian Hu
CONTINUUS Pharmaceuticals, 25R Olympia Avenue, Woburn, Massachusetts 01801, United States
6 shared publications Khrystyna Shvedova
CONTINUUS Pharmaceuticals, 25R Olympia Avenue, Woburn, Massachusetts 01801, United States
6 shared publicationsWei Wu
CONTINUUS Pharmaceuticals, 25R Olympia Avenue, Woburn, Massachusetts 01801, United States
6 shared publicationsSukumar Ramanujam
USV Private Limited, Arvind Vithal Gandhi Chowk, BSD Marg, Station Road, Govandi East, Mumbai 400080, India
5 shared publicationsAnjana Ramnath
CONTINUUS Pharmaceuticals, 25R Olympia Ave, Woburn, Massachusetts 01801, United States
4 shared publications
Latest Publications
- 3 February 2021
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 25 (2) , 225-238
Heterogeneous Crystallization as a Process Intensification Technology in an Integrated Continuous Manufacturing Process for Pharmaceuticals
- 3 February 2021
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 25 (2) , 225-238
Heterogeneous Crystallization as a Process Intensification Technology in an Integrated Continuous Manufacturing Process for Pharmaceuticals
- 21 October 2020
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 24 (12) , 2874-2889
Design and Commercialization of an End-to-End Continuous Pharmaceutical Production Process: A Pilot Plant Case Study
- 21 October 2020
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 24 (12) , 2874-2889
Design and Commercialization of an End-to-End Continuous Pharmaceutical Production Process: A Pilot Plant Case Study
- 21 August 2020
- Published by Royal Society of Chemistry (RSC) in Reaction Chemistry & Engineering
- Vol. 5 (10) , 1950-1962
Continuous reactive crystallization of an API in PFR-CSTR cascade with in-line PATs
The influence of PFR on crystal size distribution, reaction and crystallization yields, and supersaturation level was investigated.
- 21 August 2020
- Published by Royal Society of Chemistry (RSC) in Reaction Chemistry & Engineering
- Vol. 5 (10) , 1950-1962
Continuous reactive crystallization of an API in PFR-CSTR cascade with in-line PATs
The influence of PFR on crystal size distribution, reaction and crystallization yields, and supersaturation level was investigated.
- 12 June 2020
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 24 (10) , 1996-2003
Design of a Continuous Solvent Recovery System for End-to-End Integrated Continuous Manufacturing of Pharmaceuticals
- 12 June 2020
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 24 (10) , 1996-2003
Design of a Continuous Solvent Recovery System for End-to-End Integrated Continuous Manufacturing of Pharmaceuticals
- 11 June 2020
- Published by Royal Society of Chemistry (RSC) in Green Chemistry
- Vol. 22 (13) , 4350-4356
E-factor analysis of a pilot plant for end-to-end integrated continuous manufacturing (ICM) of pharmaceuticals
Much less waste was generated by the end-to-end Integrated Continuous Manufacturing (ICM) process compared to the batch process.
- 11 June 2020
- Published by Royal Society of Chemistry (RSC) in Green Chemistry
- Vol. 22 (13) , 4350-4356
E-factor analysis of a pilot plant for end-to-end integrated continuous manufacturing (ICM) of pharmaceuticals
Much less waste was generated by the end-to-end Integrated Continuous Manufacturing (ICM) process compared to the batch process.
- 9 December 2019
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 56 (7) , 1026-1029
An automated modular assembly line for drugs in a miniaturized plant
We report here a fully automated, end-to-end, integrated continuous manufacturing process for a small-molecule generic medication with built-in quality assurance. The entire process fits into a box of 30.7 m2 modular footprint and a total residence time of less than 30 h, with a throughput up to 40.3 × 106 tablets per year.
- 9 December 2019
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 56 (7) , 1026-1029
An automated modular assembly line for drugs in a miniaturized plant
We report here a fully automated, end-to-end, integrated continuous manufacturing process for a small-molecule generic medication with built-in quality assurance. The entire process fits into a box of 30.7 m2 modular footprint and a total residence time of less than 30 h, with a throughput up to 40.3 × 106 tablets per year.